Jazz Pharmaceuticals plc (JAZZ) Financials
JAZZ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 11.9 billion | 7.3 billion |
| Dec. 31, 2025 | 11.7 billion | 7.3 billion |
| Sept. 30, 2025 | 11.4 billion | 7.4 billion |
| June 30, 2025 | 10.9 billion | 7.2 billion |
JAZZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 388.5 million | 74.5 million |
| Dec. 31, 2025 | 296.8 million | 199.8 million |
| Sept. 30, 2025 | 459.4 million | 88.1 million |
| June 30, 2025 | 100.9 million | 64.5 million |
JAZZ Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 293.1 million |
| Dec. 31, 2025 | -903.6 million |
| Sept. 30, 2025 | 251.4 million |
| June 30, 2025 | -718.5 million |
JAZZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 2.9 billion | 4.3 billion | 62.2 million |
| Dec. 31, 2025 | 2.4 billion | 4.3 billion | 50.9 million |
| Sept. 30, 2025 | 2.0 billion | 4.3 billion | 53.4 million |
| June 30, 2025 | 1.7 billion | 4.3 billion | 69.0 million |
JAZZ Shares Outstanding
JAZZ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 19.7 million | 134.1 million | 352.7 million | - |
| Dec. 31, 2025 | 65.7 million | 171.4 million | 406.2 million | - |
| Sept. 30, 2025 | 15.2 million | 240.7 million | 530.6 million | - |
| June 30, 2025 | 12.0 million | 190.0 million | 358.4 million | - |
JAZZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 1.1 billion | 306.4 million |
| Dec. 31, 2025 | 1.2 billion | 24.6 million |
| Sept. 30, 2025 | 1.1 billion | 257.8 million |
| June 30, 2025 | 1.0 billion | 116.3 million |
JAZZ Revenue by Segment
Graph available only for paid members. Upgrade to see it.
JAZZ
Price: $254.22
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.11 USD
P/E Ratio: 2032.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 468012
Ebitda: 136.8 millionMarket Capitalization: 15.3 billion